Risk factors for mortality in chronic obstructive pulmonary disease;Factores de riesgo de mortalidad en la EPOC

Archivos de Bronconeumologia

Volumn 43, Issue 8, 2007, Pages 445-449

  Solanes, Ingrid ^a,c   Casan, Pere ^a   Sangenís, Mercè ^a   Calaf, Núria ^a   Giraldo, Beatriz ^b   Güell, Rosa ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

COPD; Exercise tolerance; Mortality; Survival

Indexed keywords

CARBON DIOXIDE; CARBON MONOXIDE; OXYGEN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG MINUTE VOLUME; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN TENSION; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL VOLUME; SURVIVAL; TOTAL LUNG CAPACITY; UNIVARIATE ANALYSIS; WALKING;

EID: 34548555984     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13108784     Document Type: Article

References (31)

1. ATS statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S78-S119.
2. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133:14-20.
3. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000;356:1313-7.
4. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:961-6.
5. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20:539-44.
6. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-40.
7. Redline S. The epidemiology of COPD. En: Chernicack N, editor. Obstructive pulmonary disease. Philadelphia: WB Saunders Company; 1991.
8. Sanchis J, Casan P, Castillo J, González N, Palenciano L, Roca J. Normativa para la práctica de la espirometría forzada. Arch Bronconeumol. 1989;25:132-42.
9. Cotes JE. Lung function: assessment and applications in medicine. 5th ed. London: Blackwell Scientific Publications; 1993.
10. Jones NL. Clinical exercise testing. 4th ed. Philadelphia: WB Saunders Company; 1997.
11. Buteland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J. 1982;284:1607-8.
12. Güell R, Casan P, Sangenís M, Santis J, Morante F, Borrás JM, et al. Traducción española y validación de un cuestionario de calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 1995;31:202-10.
13. Doménech JM. UD12: modelos de regresión con datos de supervivencia. En: Doménech JM, editor. Análisis multivariante: modelos de regresión. Barcelona: Signo; 2002.
14. Doménech JM. Análisis de supervivencia. En: Doménech JM, editor. Análisis multivariante: modelos de regresión: Barcelona: Signo; 2002.
15. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544-9.
16. Agustí AGN, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347-60.
17. Hunter AM, Carey MA, Larsh HW. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1981;124:376-81.
18. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000;55:848-53.
19. Yan S, Kaminski D, Sliwinski P. Inspiratory muscle mechanics of patients with chronic obstructive pulmonary disease during incremental exercise. Am J Respir Crit Care Med. 1997;156:807-13.
20. Agustí AGN, Sauleda J, Miralles C, Gómez C, Togores B, Sala E, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:485-9.
21. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL. Variables related to increased mortality following outpatient pulmonary rehabilitation. Eur Respir J. 1996;9:431-5.
22. Bowen JB, Votto JJ, Thrall RS, Haggerty MC, Stockdale-Woolley R, Bandyopadhyay T, et al. Functional status and survival following pulmonary rehabilitation. Chest. 2000;118:697-703.
23. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28-33.
24. Celli BR, Cote CG, Marín JM, Casanova C, Montes de Oca, Méndez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
25. Domingo-Salvany A, Lamarca R, Ferrer M, García-Aymerich J, Alonso J, Félez M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:680-5.
26. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122:823-32.
27. Schols AMWJ, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791-7.
28. Martínez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173:1326-34.
29. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856-61.
30. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809-13.
31. Mador MJ. Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:787-9.